Skip to main content
. 2018 Dec 3;8:17544. doi: 10.1038/s41598-018-35978-0

Figure 4.

Figure 4

Midostaurin reduces Tregs in AML cells. (A) Representative contour plots of T cell populations from patients with AML treated with midostaurin. (B) In vitro PBMCs were treated with one of the four kinase inhibitors and normalized to IL-2/IL-7 control population percentages (n = 4, p < 0.05). (C) FOXP3 mRNA expression in AML PBMCs (n = 4) treated ex vivo with 1uM of midostaurin. (D) Cytokine levels in picograms/ml were measured in AML cells treated supernatants and normalized to IL-2/IL-7 treated group (N = 5).